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Abstract 15 
Due to the enormous variety of phytochemicals present in plants, their extracts have 16 
been used for centuries in the treatment of innumerous diseases, being perceived as an 17 
invaluable source of medicines for humans. Furthermore, the combination of different 18 
plants was reported as inducing an improved effect (synergism) in comparison to the 19 
additive activity of the plants present in those mixtures. Nevertheless, information 20 
regarding the effects of plant infusions added with honey is still rather scarce. 21 
Accordingly, the aim of this study was evaluating the interaction between chestnut 22 
honey, a natural product with well-reported beneficial properties, and three medicinal 23 
plants (either as single plant or as combinations of two and three plants), with regard to 24 
their antioxidant activity and hepatotoxicity. Antioxidant activity was evaluated by 25 
comparing the results from four different assays; the hepatotoxicity was assessed in two 26 
different cell lines. Results were compared by analysis of variance and linear 27 
discriminant analysis. The addition of honey to the infusions had a beneficial result in 28 
both cases, producing a synergistic effect in all samples, except β-carotene bleaching 29 
inhibition for artichoke+milk thistle+honey preparation and also preparations with 30 
lower hepatotoxicity, except in the case of artichoke+honey. Moreover, from 31 
discriminant linear analysis output, it became obvious that the effect of honey addition 32 
overcame that resulting from using single plant or mixed plants based infusions. Also, 33 
the enhanced antioxidant activity of infusions containing honey was convoyed by a 34 
lower hepatotoxicity.  35 
 36 
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 39 
Introduction 40 
Medicinal plants have been used for centuries in the treatment of innumerous diseases, 41 
either as single plant or as combinations of different plants crude extracts or herbal 42 
remedies.1 The enormous variety of phytochemicals present in plants has positioned 43 
them as an invaluable source of medicines for humans, even after the latest advances in 44 
synthetic drug development.2 Moreover, their beneficial effects seem to be improved in 45 
combinations of herbal remedies due to synergistic effects between different plants.  46 
In order to avail this kind of interactions, there are several studies supporting the 47 
optimization of plant-based products application and aiming to explain the mechanisms 48 
underlying synergistic actions between bioactive compounds of different herbs.3,4 For 49 
instance, according to Wagner,5 this kind of interaction can be explained by synergistic 50 
multi-target effects; pharmacokinetic or physicochemical effects; antagonization of 51 
resistance mechanisms of pathogenic microorganisms (bacteria, fungi) or tumor cells by 52 
natural products (e.g., polyphenols); and elimination or neutralization of toxic or 53 
adversely acting substances by one agent that has been added to an extract. Actually, 54 
those mechanisms could explain the results obtained by our research group in a previous 55 
study involving combinations of syrups based on hepatoprotective plants, where the 56 
antioxidant and anti-hepatocellular carcinoma activities were increased in the samples 57 
containing extracts from various plants.6 58 
In addition, honey, a supersaturated sugar solution produced by honey bees from nectar 59 
of different plants, possesses a valued place in traditional medicine, with well-reported 60 
health benefits.7 This natural product proved to act as an antioxidant, antitumoral, 61 
hepatoprotective, antiviral, antibacterial, antifungal and immune-stimulant agent in 62 
several studies, and is being used in the treatment of skin diseases, urinary tract 63 
disorders, gastroenteritis, gastric ulcer, worm infestations, and as reducer of poison 64 
effects, among many other applications.8,9 Furthermore, in a previous study of our 65 
research group, honey also revealed the ability to potentiate the antioxidant properties of 66 
lemon flavored black tea, increasing reducing power and lipid peroxidation inhibition 67 
properties, as also phenolics, flavonoids and ascorbic acid contents.10 68 
With that in mind, in the present study we aimed to exploit the possible synergism 69 
between mixtures of honey and infusions of three medicinal plants (either as single 70 
plant or as combinations of two and three plants), with regard to their antioxidant 71 
activity and hepatotoxicity.  72 
 73 
Material and Methods 74 
Samples and samples preparation 75 
Three medicinal plants used for hepatoprotective purposes were obtained from an 76 
herbalist shop in Bragança (Portugal), as dry material for infusions: Cynara scolymus L. 77 
(artichoke, leaves), Cochlospermum angolensis Welw. (borututu, bark) and Silybum 78 
marianum (L.) Gaertn (milk thistle, plant). The honey was harvested by local 79 
beekeepers in the Bragança region, from areas with high density of chestnut orchards.  80 
The infusions were prepared by adding 1 g of plant material (1 g of each plant for 81 
individual infusions, 0.5 g of each plant for mixtures of two plants, and 0.33 g of each 82 
plant for mixtures containing the three plants) to 100 mL of boiling distilled water and 83 
filtering after 5 min of standing. For the infusions containing honey, the same procedure 84 
was followed, but 5 g (the equivalent to a teaspoon) of honey were added after the 85 
filtration process. Thus, the following samples were studied: i) eight control samples 86 
(plants or honey separately); three individual infusions (artichoke, borututu or milk 87 
thistle), three infusions containing two plants (artichoke+borututu, artichoke+milk 88 
thistle and borututu+milk thistle), one infusion containing the three plants 89 
(artichoke+borututu+milk thistle), and honey dissolved in boiled water (5 g in 100 mL); 90 
ii) seven mixtures of plants and honey: three individual infusions with honey 91 
(artichoke+honey, borututu+honey or milk thistle+honey), three infusions containing 92 
two plants with honey (artichoke+borututu+honey, artichoke+milk thistle+honey and 93 
borututu+milk thistle+honey), and one infusion containing the three plants with honey 94 
(artichoke+borututu+milk thistle+honey). 95 
The concentrations for the control infusions and honey were: 10 mg/mL of dried plant 96 
(5 and 3.33 mg/mL for each plant in the infusions containing two and three plants, 97 
respectively) and 47.62 mg/mL of honey. For the mixtures containing the plant 98 
infusions and honey, the concentrations were 9.52 mg/mL of dried plant (4.76  and 3.17 99 
mg/mL for each plant in the mixtures containing infusions of two and three plants, 100 
respectively) and 47.62 mg/mL of honey (Table 2). These fifteen solutions were 101 
successively diluted and submitted to an evaluation of antioxidant activity and 102 
hepatotoxicity using two different cell lines. 103 
 104 
Standards and reagents  105 
2,2-Diphenyl-1-picrylhydrazyl (DPPH) was obtained from Alfa Aesar (Ward Hill, 106 
USA). Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid), ellipticine, 107 
phosphate buffered saline (PBS), acetic acid, sulforhodamine B (SRB), trichloroacetic 108 
acid (TCA), Tris, ninhydrin and sugar standards (D(-)-fructose, D(+)-sucrose, D(+)-109 
glucose, D(+)-trehalose, D(+)-turanose, D(+)-maltulose, D(+)-maltose, D(+)-110 
melezitose) were purchased from Sigma (St. Louis, MO, USA). For HMF determination 111 
Carrez´s I and II reagents were used and obtained from Panreac (Barcelona, Spain). 112 
Phadebas was acquired by Magle AB (Lund, Sweden). Foetal bovine serum (FBS), L-113 
glutamine, Hank’s balanced salt solution (HBSS), trypsin-EDTA 114 
(ethylenediaminetetraacetic acid), nonessential amino acids solution (2 mM), 115 
penicillin/streptomycin solution (100 U/mL and 100 mg/mL, respectively) and DMEM 116 
(Dulbecco's Modified Eagle Medium) were from Hyclone (Logan, USA). All other 117 
solvents and reagents were of analytical grade and purchased by a common source. 118 
Water was treated in a Milli-Q water purification system (TGI Pure Water Systems, 119 
USA).  120 
 121 
Honey quality  122 
The quality analysis of honey was established following the methods described by the 123 
International Honey Commission11 for physicochemical characterization of honey: color 124 
index was determined by a colorimeter C221 (Hanna Instruments, Woonsocket, RI, 125 
USA) and classified according to the Pfund scale; the moisture content was measured 126 
by refractometry using a portable refractometer; the electrical conductivity was measure 127 
in a 20% honey solution (dry matter) and expressed as µScm-1 (Crison, micro pH 2001 128 
model); pH and free acidity was obtained in a aqueous honey solution (10 g/75 mL) by 129 
potentiometry, using NaOH 0.1 moldm-3 (Crison, micro pH 2001 model); HMF was 130 
analyzed by spectrophotometry at 284 and 336 nm (Specord 200 spectrophotometer, 131 
Analytikjena, Jena, Germany) according to White and expressed as mgkg-1 of honey; 132 
diastasis activity was evaluated by the Phadebas method and expressed as diastase 133 
number (DN); proline content was determined by spectrophotometry measuring the 134 
colored complex formed with ninhydrin at 510 nm (Specord 200 spectrophotometer, 135 
Analytikjena, Jena, Germany) and expresses as mgkg-1 of honey. Sugar profile was 136 
evaluated by high performance liquid chromatography coupled to a refraction index 137 
detector (HPLC-RI), after re-dissolving the honey samples in water:methanol (25:75, 138 
v/v).11 The equipment consisted of an integrated system with a pump (Knauer, Smartline 139 
system 1000, Berlin, Germany), degasser system (Smartline manager 5000), auto-140 
sampler (AS-2057 Jasco, Easton, MD, USA) and an RI detector (Knauer Smartline 141 
2300). Data were analysed using Clarity 2.4 Software (DataApex, Prague, Czech 142 
Republic). The chromatographic separation was achieved with a Eurospher 100-5 NH2 143 
column (4.6×250 mm, 5 µm, Knauer) operating at 30 ºC (7971 R Grace oven). The 144 
mobile phase was acetonitrile/deionized water, 80:20 (v/v) at a flow rate of 1.3 mL/min. 145 
The compounds were identified by chromatographic comparisons with authentic 146 
standards. Quantification was performed using external standards methodology and the 147 
results were expressed in g/100 g of honey. 148 
The botanical origin of honey was achieved by pollen analysis, according to the 149 
harmonized methods for melissopalynology.12 150 
 151 
Evaluation of antioxidant activity 152 
DPPH radical-scavenging activity was evaluated by using an ELX800 microplate reader 153 
(Bio-Tek Instruments, Inc; Winooski, VT, USA), and calculated as a percentage of 154 
DPPH discolouration using the formula: [(ADPPH-AS)/ADPPH] × 100, where AS is the 155 
absorbance of the solution containing the sample at 515 nm, and ADPPH is the 156 
absorbance of the DPPH solution. Reducing power was evaluated by the capacity to 157 
convert Fe3+ into Fe2+, measuring the absorbance at 690 nm in the microplate reader 158 
mentioned above. Inhibition of β-carotene bleaching was evaluated though the β-159 
carotene/linoleate assay; the neutralization of linoleate free radicals avoids β-carotene 160 
bleaching, which is measured by the formula: β-carotene absorbance after 2h of 161 
assay/initial absorbance) × 100. Lipid peroxidation inhibition in porcine (Sus scrofa) 162 
brain homogenates was evaluated by the decreasing in thiobarbituric acid reactive 163 
substances (TBARS); the colour intensity of the malondialdehyde-thiobarbituric acid 164 
(MDA-TBA) was measured by its absorbance at 532 nm; the inhibition ratio (%) was 165 
calculated using the following formula: [(A - B)/A] × 100%, where A and B were the 166 
absorbance of the control and the sample solution, respectively.13 The results were 167 
expressed in EC50 values (sample concentration providing 50% of antioxidant activity 168 
or 0.5 of absorbance in the reducing power assay). Trolox was used as positive control. 169 
 170 
Evaluation of hepatotoxicity  171 
The hepatotoxicity was evaluated using two different cell lines: HepG2, which is the 172 
most widely used tumor cell line and generally regarded as a good hepatocellular 173 
carcinoma model; and PLP2, a cell culture prepared from a freshly harvested porcine 174 
liver obtained from a local slaughter house, according to a procedure established by the 175 
authors.14 176 
HepG2 cells were routinely maintained as adherent cell cultures in RPMI-1640 177 
supplemented with 10% FBS, 2 mM glutamine, at 37 ºC, in a humidified air incubator 178 
containing 5% CO2. The cell line was plated at 1.0 × 104 cells/well in 96-well plates. 179 
Sulforhodamine B assay was performed according to a procedure previously described 180 
by the authors.14 181 
Cultivation of the PLP2 cells was continued with direct monitoring every two to three 182 
days using a phase contrast microscope. Before confluence was reached, cells were 183 
subcultured and plated in 96-well plates at a density of 1.0×104 cells/well, and in 184 
DMEM medium with 10% FBS, 100 U/mL of penicillin and 100 µg/mL of 185 
streptomycin. The results were expressed in GI50 values (sample concentration that 186 
inhibited 50% of the net cell growth). Ellipticine was used as positive control.  187 
 188 
Theoretical values and obtained effect calculation 189 
The theoretical values were calculated from the EC50 values (Table 3) obtained for 190 
preparations without honey and for the samples containing only honey (H), considering 191 
the exact concentration of each component.15 For instance, the theoretical values for 192 
ABH were calculated as: 193 
 194 
Where, 10 is the concentration of the solution before adding the 5 g of honey, and 9.52 195 
is the concentration afterwards; the concentration of honey was considered as being 196 
maintained unaltered due to the negligible contribution of the extract mass to the total 197 
mass of the solution.  198 
 199 
The obtained effect was calculated by applying the formula: 200 
 201 
 202 
It was further classified as synergistic (SN): E ≥ 0.05; additive (AD): -0.05 < E < 0.05; 203 
antagonistic: E ≤ -0.05.15 204 
 205 
Statistical analysis 206 
For all the experiments three samples (n=3) were analyzed and all the assays were 207 
carried out in triplicate. The results are expressed as mean values ± standard deviation 208 
(SD). All statistical tests were performed at a 5% significance level using IBM SPSS 209 
Statistics for Windows, version 22.0. (IBM Corp., USA). 210 
The differences between the infusions were analyzed using one-way analysis of 211 
variance (ANOVA). The fulfilment of the one-way ANOVA requirements, specifically 212 
the normal distribution of the residuals and the homogeneity of variance, was tested by 213 
means of the Shapiro Wilk’s and the Levene’s tests, respectively. All dependent 214 
variables were compared using Tukey’s honestly significant difference (HSD) or 215 
Tamhane’s T2 multiple comparison tests, when homoscedasticity was verified or not, 216 
respectively. 217 
Furthermore, a linear discriminant analysis (LDA) was used to study the combined 218 
effect on the antioxidant activity and hepatotoxicity of the infusions prepared with the 219 
addition of honey. A stepwise technique, using the Wilks’ λ method with the usual 220 
probabilities of F (3.84 to enter and 2.71 to remove), was applied for variable selection. 221 
This procedure uses a combination of forward selection and backward elimination 222 
processes, where the inclusion of a new variable is preceded by ensuring that all 223 
variables selected previously remain significant.16,17 With this approach, it is possible to 224 
determine which of the independent variables account most for the differences in the 225 
average score profiles of the different infusions. To verify the significance of canonical 226 
discriminant functions, the Wilks’ λ test was applied. A leaving-one-out cross-227 
validation procedure was carried out to assess the model performance. 228 
 229 
Results and Discussion 230 
Honey quality  231 
The quality of honey is highly dependent on the botanical origin of the nectar source, 232 
and so, its properties. Dark honeys are generally known to present a higher antioxidant 233 
activity than light-colored honeys,18 which is explained by the presence of several 234 
phytochemicals in its composition, particularly phenolic compounds. Chestnut honey, 235 
very characteristic of Mediterranean countries, is identified by its dark-reddish color and 236 
high electrical conductivity due to a high mineral content, what makes a good candidate 237 
to be used as nutraceutical. Recent studies proved that the fortification of yogurts with 238 
chestnut honey accounts to an increase in the antioxidant activity of the final product.19 239 
The melissopalynological results for the honey sample use in this study revealed a high 240 
content of Castanea sativa pollen close to 70 %. This botanical classification is 241 
confirmed by its physicochemical features such as a dark amber color and the high 242 
electrical conductivity, which reaches more than 1100 µscm-1, Table 1. The low acidity 243 
and high content in the amino acid proline was also observed, with a ratio of 244 
fructose/glucose well above 1.2, characteristic of honeys with low tendency for 245 
crystallization. The sugar profile of chestnut honey presents typically a higher content 246 
of the monosaccharide fructose compared to glucose, with some traces of 247 
oligosaccharides that arise from the collection of honeydew by the bees, due to the late 248 
season harvesting of this type of honey. These findings can be observed in the footnote 249 
of Table 1, with the presence of a small amount of the trisaccharide melezitose. 250 
The other quality parameters such as humidity, HMF, diastase and sugar content, Table 251 
1, all certify the sample as a good quality honey, with the values fitting within the 252 
international standards for honey.20,21 253 
  254 
Antioxidant activity and hepatotoxicity  255 
The human organism is provided with a remarkably efficient endogenous antioxidant 256 
system. Nevertheless, this system may not be enough, forcing humans to depend on 257 
exogenous antioxidants that are obtained by dietary intake. Even though, the effects of 258 
those natural antioxidants rely on several conditions, and their action may even result as 259 
prooxidant under specific circumstances.22 In this context, the effectiveness of herbal 260 
formulations has been receiving high attention, since dietary supplements/nutraceuticals 261 
and some pharmaceutical products based on the extraction of bioactive compounds from 262 
natural matrices are one of the top exogenous sources of antioxidants.23 263 
Herein it was intended to evaluate the effect of adding honey to infusions of three 264 
highly disseminated plants: Cynara scolymus L. (artichoke, leaves), Cochlospermum 265 
angolensis Welw. (borututu, bark) and Silybum marianum (L.) Gaertn (milk thistle, 266 
plant). Infusions were prepared using single plants, mixtures of two plants and also 267 
using the three plants together. A chestnut based honey was selected according to its 268 
high antioxidant activity. Due to the quantities of dried plants and honey commonly 269 
used to prepare infusion-based or decoction-based beverages, it is important to assess 270 
the maintenance/improvement of the antioxidant activity in the consumed products 271 
instead of an undesirable reduced activity/prooxidant effect. Bearing this in mind, four 272 
different assays were used: DPPH scavenging activity, reducing power (assessed by 273 
Ferricyanide/Prussian blue assay), β-carotene bleaching inhibition and TBARS 274 
formation inhibition. The hepatotoxicity of the prepared formulations was also 275 
evaluated using a human hepatocellular carcinoma line (HepG2) and a primary porcine 276 
liver cell culture (PLP2). The toxicity assessment is obligatory due to the potential toxic 277 
effects of compounds naturally present in the prepared infusions.24 278 
All infusions were prepared according to common practices. The concentrations of each 279 
component are shown in Table 2. Initially, the infusions were prepared using individual 280 
components: honey (H), artichoke (A), borututu (B) and milk thistle (M), or mixtures: 281 
AB, AM, BM and ABM. The results for the antioxidant activity of these preparations 282 
are presented in Table 3. In general, the antioxidant activity of the infusions prepared 283 
only with honey was weaker than the obtained using plant infusions. Among these, 284 
preparations containing B showed the highest antioxidant activity. The obtained values 285 
are in the expected range, considering previously reported results.25 As it can also be 286 
depicted from Table 3, A (or two-plant mixtures containing A) showed the highest 287 
hepatotoxicity, but the prepared beverages might be considered as having low levels for 288 
this indicator. In fact, none of the samples (except H, which produced a GI50 = 2.2 289 
mg/mL) was hepatotoxic (up to the assayed concentrations) in the assays carried on 290 
PLP2 cell lines.   291 
The same bioactive indicators (antioxidant activity and hepatotoxicity) were evaluated 292 
in infusions containing the same plant composition plus honey (AH, BH, MH, ABH, 293 
AMH, BMH and ABMH), in order to verify the practical effect of adding this 294 
component to each of the prepared infusions. The results obtained in experimental 295 
assays were compared to theoretically predicted values to verify the occurrence of 296 
antagonistic, additive or synergistic effects.  297 
As it can be reasoned from Table 4, the addition of honey to the infusions had a 298 
beneficial effect, producing a synergistic effect in all cases, except β-carotene bleaching 299 
inhibition for AMH preparation. Regarding the specific effect on each antioxidant 300 
assay, it might be concluded that TBARS formation inhibition and DPPH scavenging 301 
activity were improved in a higher extent. Concerning the assayed preparations, BH and 302 
BMH showed the highest increase in antioxidant activity, independently of the tested 303 
assay.  304 
Due to the lack of GI50 values for B, M, BM and ABM, it was not possible to calculate 305 
the theoretical values for BH, MH, BMH and ABMH. Nevertheless, considering the 306 
cases in which these calculations were possible, it might be concluded that the addition 307 
of H contributed to reduce the hepatotoxicity of the prepared infusions (except in the 308 
case of AH). 309 
 310 
Linear Discriminant Analysis 311 
In order to have a complete perspective about the effect of H addition on the antioxidant 312 
activity, a linear discriminant analysis was applied (the hepatotoxicity results were not 313 
included, since the GI50 were not available for all cases). The basic purpose of this 314 
discriminant analysis was estimating the connection between a single categorical 315 
dependent variable (infusion formulation) and a set of quantitative independent 316 
variables (the EC50 values obtained in the antioxidant assays). The significant 317 
independent variables were selected following the stepwise method of the LDA, 318 
according to the Wilks’ λ test. Only variables with a statistically significant 319 
classification performance (p < 0.05) were kept in the analysis.  320 
In order to simplify the interpretation of results, and also to increase their scope of 321 
application, the 15 prepared formulations were aggregated in seven groups: honey (H), 322 
1 plant (A, B and M), 1 plant + honey (AH, BH, MH), 2 plants (AB, AM, BM), 2 plants 323 
+ honey (ABH, AMH, BMH), 3 plants (ABM) and 3 plants + honey (ABMH). 324 
The discriminant model selected 4 significant functions, which included 100.0% of the 325 
observed variance. The graph representation (Figure 1) of the three first functions 326 
(function 1: 70.1%, function 2: 27.2%, function 3: 2.3%) was included to assess the 327 
association of the analyzed infusions based on their antioxidant activity. The tested 328 
groups were not completely individualized, but it is interesting to verify that all markers 329 
corresponding to infusions added with honey (shadowed markers) were proximately 330 
distributed (despite the overlapping of some markers corresponding to “2 plants”). This 331 
observation was corroborated by the corresponding contingency matrix (Table 4). The 332 
classification performance allowed 56% of correctly classified samples (sensitivity) and 333 
66% of overall specificity within the leave-one-out cross-validation procedure, which 334 
may be considered as acceptable values. The displayed results show that all samples 335 
including H in its preparation were classified in groups corresponding to infusions 336 
prepared with this component (from the 27 “1 plant + honey” samples, 19 were 337 
correctly classified and 8 were classified as “2 plants + honey”; from the 27 “2 plants + 338 
honey” samples, 12 were correctly classified, 6 were classified as “1 plant + honey” and 339 
9 were classified as “3 plants + honey”; all the “3 plants + honey” samples were 340 
correctly classified). This result, together with the differences observed in Table 4, is a 341 
strong indication of the distinctively beneficial effect of H addition in the antioxidant 342 
activity of these infusions. It is also noteworthy that 9 “1 plant” samples were classified 343 
as “3 plants” and that none of the “2 plants” samples was correctly classified as “2 344 
plants”. Accordingly, this might indicate that the enhancing effect induced by H 345 
overcomes the potential effects of using one or two plants to prepare a determined 346 
infusion, which is so often reported. Furthermore, and despite the lack of scientific 347 
evidence, it might be considered that preparations added with H have an improved 348 
flavor (increased sweetness and less bitterness), favoring the acceptance of a wider 349 
number of consumers.  350 
 351 
Conclusions 352 
Overall, the results obtained in this work proved the utility of honey addition to 353 
potentiate the antioxidant and cytoprotective properties of medicinal plant based 354 
infusions. Since the used infusions were prepared following common practices, these 355 
findings might have a direct practical application among the consumers of these 356 
infusions. The increased antioxidant activity was verified independently of using one, 357 
two or three plants based infusions, potentiating their effects in every single cases 358 
(except β-carotene bleaching inhibition for AMH preparation).  From the LDA output, it 359 
was possible to conclude that the effect of honey addition overcame that resulting from 360 
using single plant or mixed plants based infusions. The enhanced antioxidant activity 361 
coupled to the lower hepatotoxicity showed by formulations containing honey might be 362 
helpful to define the most suitable practice in terms of infusion preparation. 363 
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Table 1. Honey quality parameters.  
Parameters Honey sample Standard Regulations 
Color (mm Pfund) Dark Ambar Dark to very dark 
Humidity (%) 14.6 ± 0.0 Less than 20 
Conductivity (µs/cm) 1167.3 ± 0.6 Above 800 
HMF (mg/kg) 0.7 ± 0.2 Below 40 
Free acidity (meq/kg) 15.3 ± 0.6 Low values 
Lactonic acidity (meq/kg) 11.3 ± 0.3 - 
Total acidity (meq/g) 26 ± 1 - 
Reducing sugars (g/100 g) 74.0 ± 0.4 Above 60 
Proline (mg/kg) 1158 ± 42 High values 
Diastase (DN) 28.3 ± 0.3 - 
Sucrose (g/100 g) 0.7 ± 0.0 Below 5 
Fructose/Glucose ratio* 1.36 High values 
*The sugars detected (g/100 g) in the sample of honey were fructose (42.6 ± 0.2), glucose (31.4 ± 0.4), 
sucrose (0.7 ± 0.0), turanose (2.5 ± 0.1), maltulose (3.2 ± 0.1), maltose (0.2 ± 0.0), trehalose (1.6 ± 0.0) 
and melezitose (0.4 ± 0.1).   
 
 
 Table 2. Concentrations of components included in each sample/mixture.  
Concentration (mg/g of solution)* 
Sample/Mixture 
H A B M 
Honey (H) 47.62 - - - 
Artichoke (A) - 10 - - 
Borututu (B) - - 10 - 
Milk thistle (M) - - - 10 
AH 47.62 9.52 - - 
BH 47.62 - 9.52 - 
MH 47.62 - - 9.52 
AB - 5 5 - 
AM - 5 - 5 
BM - - 5 5 
ABH 47.62 4.76 4.76 - 
AMH 47.62 4.76 - 4.76 
BMH 47.62 - 4.76 4.76 
ABM - 3.33 3.33 3.33 
ABMH 47.62 3.17 3.17 3.17 
*Mixtures containing honey were considered as having a total mass of 105 g (100 g of water and 5 g of 
honey). The contribution of the mass extract obtained for each infusion was considered as negligible.  
 
Table 3. Antioxidant activity (EC50 values, mg/mL) and hepatotoxicity (GI50 values, mg/mL) of the honey solution and of the infusions prepared 







inhibition TBARS inhibition 
HepG2 
(hepatocellular carcinoma) 
Honey (H) 33.7±0.5 a 6.5±0.1 a 10.0±0.5 a 5.2±0.1 a 1.4±0.2 a 
Artichoke (A) 8.8±0.3 c 3.8±0.1 d 1.01±0.03 e 3.43±0.03 c 0.09±0.01 b 
Borututu (B) 1.5±0.1 f 0.79±0.01 h 1.31±0.05 d 0.22±0.01 g NT 
Milk thistle (M) 4.4±0.1 d 5.0±0.1 c 1.31±0.05 d 4.1±0.1 b NT 
AB 2.3±0.1 e 1.1±0.1 g 1.55±0.05 d 0.27±0.01 g 0.20±0.01 b 
AM 12.1±0.2 b 5.3±0.1 b 2.2±0.1 b 2.49±0.04 d 0.18±0.01 b 
BM 1.9±0.1 e 1.3±0.1 f 1.86±0.04 c 0.48±0.02 f NT 
ABM 2.2±0.1 e 1.7±0.1 e 1.05±0.04 e 0.72±0.02 e NT 
Homoscedasticity2 <0.001 0.047 <0.001 <0.001 <0.001 
p-values 1-way ANOVA3 <0.001 <0.001 <0.001 <0.001 <0.001 
Positive control*  41±1 41.7±0.3 18±1 22.8±0.7 1.10±0.08 
 
NT - Non-toxic up to 0.5 mg/mL of plants in the infusion. *Trolox and ellipticine for antioxidant and hepatotoxicity assays, respectively (only in this case, the results are 
expressed in µg/mL). EC50 values correspond to the sample concentration achieving 50% of antioxidant activity or 0.5 of absorbance in reducing power assay. GI50 values 
correspond to the sample concentration achieving 50% of growth inhibition in HepG2. 1The results, analyzed through one-way ANOVA, are presented as the mean±SD. 
2Homoscedasticity was tested by means of the Levene test: homoscedasticity, p > 0.05; heteroscedasticity, p < 0.05. 3p < 0.05 indicates that the mean value of the assay of at 
least one infusion differs from the others (in this case multiple comparison tests were performed). For each species, means within a column with different letters differ 
significantly (p < 0.05).  
 
 
 Table 4. Theoretical1 versus experimental values of antioxidant activity (EC50 values, mg/mL) and hepatotoxicity (GI50 values, mg/mL) of 
mixtures containing honey and plant infusion(s) (artichoke, borututu and milk thistle, individual or mixed samples) (mean ± SD). 
 DPPH scavenging activity Reducing power β-carotene bleaching inhibition TBARS inhibition 
HepG2 (hepatocellular 
carcinoma) 
 Theoretical Experimental Effect Theoretical Experimental Effect Theoretical Experimental Effect Theoretical Experimental Effect Theoretical Experimental Effect 
Artichoke (A) + Honey (H) 21.5±0.3 b 19.0±0.3 a SN 5.21±0.02 c 4.6±0.2 b SN 5.5±0.2 c 4.7±0.2 c SN 4.38±0.03 b 3.2±0.1 a SN 0.8±0.1 0.65±0.01 c SN 
Borututu (B) + Honey (H) 17.6±0.3 d 5.3±0.1 e SN 3.64±0.03 g 2.2±0.1 f SN 5.7±0.2 bc 3.8±0.2 d SN 2.70±0.04 f 0.49±0.02 g SN NT - - 
Milk thistle (M) + Honey (H) 19.2±0.4 c 7.3±0.3 cd SN 5.86±0.05 b 4.7±0.1 b SN 5.7±0.2 bc 4.8±0.2 bc SN 4.72±0.04 a 2.3±0.1 b SN NT - - 
ABH 18.1±0.4 d 5.1±0.2 e SN 3.82±0.05 f 2.7±0.1 e SN 5.8±0.3 bc 5.0±0.2 b SN 2.72±0.04 f 0.89±0.01 e SN 0.8±0.1 0.97±0.04 b AN 
AMH 23.2±0.3 a 13.9±0.5 b SN 6.0±0.1 a 4.8±0.1 a SN 6.2±0.2 a 6.9±0.3 a AN 3.89±0.05 c 1.51±0.01 c SN 0.8±0.1 1.07±0.04 a AN 
BMH 17.9±0.3 d 7.0±0.4 d SN 3.9±0.1 e 2.9±0.2 d SN 6.0±0.2 ab 1.8±0.1 f SN 2.83±0.05 e 0.72±0.01 f SN NT - - 
ABMH 18.0±0.3 d 7.7±0.4 c SN 4.1±0.1 d 3.3±0.2 c SN 5.6±0.2 c 2.2±0.1 e SN 2.96±0.05 d 1.06±0.03 d SN NT - - 
Homoscedasticity2 0.901 <0.001  0.005 0.507  0.970 0.001  0.185 <0.001  0.996 0.018  
p-values 
1-way ANOVA3 <0.001 <0.001  <0.001 <0.001  <0.001 <0.001  <0.001 <0.001  0.481 <0.001  
NT - Non-toxic up to 2.38 mg/mL of honey and 0.5 mg/mL of plants in the infusion. SN- synergistic effect; AN- antagonistic (negative synergistic) effect. 
Table 5. Contingency matrix obtained using LDA based on antioxidant activity EC50 
hepatotoxicity GI50 values of mixtures containing honey and plant infusion(s) 
(artichoke, borututu and milk thistle, individual or mixed samples).
 
Predicted Group Membership 
Sample/Mixture 
Honey 1 plant 1 plant + honey 2 plants 2 plants + honey 3 plants 3 plants + honey 
total Sensitivity (%) 
Honey 9 0 0 0 0 0 0 9 100 
1 plant 0 18 0 0 0 9 0 27 67 
1 plant + honey 0 0 19 0 8 0 0 27 70 
2 plants 0 0 0 0 0 18 9 27 0 
2 plants + honey 0 0 6 0 12 0 9 27 44 
3 plants 0 0 0 0 0 9 0 9 100 
3 plants + honey 0 0 0 0 0 0 9 9 100 
total 9 18 25 0 20 36 27 135 56 
Specificity (%) 100 100 76 - 60 25 33 66  
 
 Figure 1. 
 
 
Figure 1. Mean scores of different samples/mixtures projected for the three first 
discriminant functions defined from antioxidant properties. 
 
